These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27224890)

  • 1. Role of the tumor microenvironment in regulating apoptosis and cancer progression.
    Yaacoub K; Pedeux R; Tarte K; Guillaudeux T
    Cancer Lett; 2016 Aug; 378(2):150-9. PubMed ID: 27224890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
    Servais C; Erez N
    J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the tumor microenvironment in tumor progression and the clinical applications (Review).
    Yuan Y; Jiang YC; Sun CK; Chen QM
    Oncol Rep; 2016 May; 35(5):2499-515. PubMed ID: 26986034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARP-1/CCAR1: a biphasic regulator of cancer cell growth and apoptosis.
    Muthu M; Cheriyan VT; Rishi AK
    Oncotarget; 2015 Mar; 6(9):6499-510. PubMed ID: 25894788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
    Mierke CT
    Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory fibroblasts in cancer.
    Lim H; Moon A
    Arch Pharm Res; 2016 Aug; 39(8):1021-31. PubMed ID: 27384063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment.
    Cheng HS; Lee JXT; Wahli W; Tan NS
    Mol Cancer; 2019 Mar; 18(1):51. PubMed ID: 30925918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer.
    Ferguson LP; Diaz E; Reya T
    Trends Cancer; 2021 Jul; 7(7):624-634. PubMed ID: 33509688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
    Peebles KA; Lee JM; Mao JT; Hazra S; Reckamp KL; Krysan K; Dohadwala M; Heinrich EL; Walser TC; Cui X; Baratelli FE; Garon E; Sharma S; Dubinett SM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1405-21. PubMed ID: 17944566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor microenvironment and its contribution to tumor evolution toward metastasis.
    Lorusso G; Rüegg C
    Histochem Cell Biol; 2008 Dec; 130(6):1091-103. PubMed ID: 18987874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
    Setrerrahmane S; Xu H
    Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.
    Long KB; Collier AI; Beatty GL
    Mol Immunol; 2019 Jun; 110():3-12. PubMed ID: 29273393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment and therapeutic response.
    Wu T; Dai Y
    Cancer Lett; 2017 Feb; 387():61-68. PubMed ID: 26845449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance.
    Aldinucci D; Celegato M; Casagrande N
    Cancer Lett; 2016 Sep; 380(1):243-52. PubMed ID: 26474544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.